Evidence map›Paper›PMID 23012556›Full record

ReviewSensors (Basel, Switzerland)2012

Screening of aptamers on microfluidic systems for clinical applications.

Chen-Hsun Weng, Chao-Jyun Huang, Gwo-Bin Lee

Abstract readReview
In one paragraph

Review in Sensors (Basel, Switzerland), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Aptamers used for biosensors and targeted therapy.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2020
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. The Effects of Dithiothreitol on DNA.Sensors (Basel, Switzerland) · 2017
    Article
  8. Article
  9. Aptamer and its applications in neurodegenerative diseases.Cellular and molecular life sciences : CMLS · 2017
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Nanoparticles for Improving Cancer Diagnosis.Materials science & engineering. R, Reports : a review journal · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chen-Hsun WengDepartment of Microbiology and Immunology, National Cheng Kung University, Tainan 70101, Taiwan. b88501113@gmail.com
Chao-Jyun Huang
Gwo-Bin Lee

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of microfluidic systems for screening of aptamers and their biomedical applications are reviewed in this paper. Aptamers with different nucleic acid sequences have been extensively studied and the results demonstrated a strong binding affinity to target molecules such that they can be used as promising candidate biomarkers for diagnosis and therapeutics. Recently, the aptamer screening protocol has been conducted with microfluidic-based devices. Furthermore, aptamer affinity screening by a microfluidic-based method has demonstrated remarkable advantages over competing traditional methods. In this paper, we first reviewed microfluidic systems which demonstrated efficient and rapid screening of a specific aptamer. Then, the clinical applications of screened aptamers, also performed by microfluidic systems, are further reviewed. These automated microfluidic systems can provide advantages over their conventional counterparts including more compactness, faster analysis, less sample/reagent consumption and automation. An aptamer-based compact microfluidic system for diagnosis may even lead to a point-of-care device. The use of microfluidic systems for aptamer screening and diagnosis is expected to continue growing in the near future and may make a substantial impact on biomedical applications.

Indexed as

Microfluidic Analytical TechniquesAptamers, NucleotideBiosensing TechniquesDNA, Single-StrandedSELEX Aptamer TechniqueSurface Plasmon ResonanceAptamers, NucleotideDNA, Single-StrandedaptamerbiosensorMEMSmicrofluidicsSELEX

Identifiers

PMID23012556
PMCPMC3444114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.